<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02479607</url>
  </required_header>
  <id_info>
    <org_study_id>PhONEME Breast</org_study_id>
    <nct_id>NCT02479607</nct_id>
  </id_info>
  <brief_title>Effects of an ICT-platform for Assessment and Management of Patient-reported Symptoms During Treatment for Breast Cancer</brief_title>
  <acronym>PhONEME</acronym>
  <official_title>PhONEME - ParticipatOn Ehealth MobilE. Effects of an Interactive ICT-platform for Assessment and Management of Symptoms in Patients Treated for Breast Cancer.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Karolinska University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effects of an interactive Information and
      Communication Technologies (ICT) -platform for use in a smartphone or tablet in patients
      treated with neoadjuvant chemotherapy for breast cancer. The hypothesis is that clinical
      management will be improved and costs reduced and safe and participatory care promoted, when
      patients report symptoms in an application which provides self-care advice and instant access
      to professionals.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 30, 2015</start_date>
  <completion_date type="Actual">October 2017</completion_date>
  <primary_completion_date type="Actual">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Questionnaire Scale for Functional Health Literacy (S-FHL-Swedish version)</measure>
    <time_frame>Up to 3 months after completion of neoadjuvant chemotherapy treatment</time_frame>
    <description>To evaluate self-reported data in terms of understanding health</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Questionnaire Scale for Communicative and Critical Health Literacy (S-C &amp; C HL - Swedish version)</measure>
    <time_frame>Up to 3 months after completion of neoadjuvant chemotherapy treatment</time_frame>
    <description>To evaluate self-reported data in terms of communicating health</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Questionnaire Individualized Care Scale (ICS)</measure>
    <time_frame>Up to 3 months after completion of neoadjuvant chemotherapy treatment</time_frame>
    <description>To evaluate self-reported data in terms of individualized care</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Questionnaire Sense of Coherence Scale (KASAM)</measure>
    <time_frame>Up to 3 months after completion of neoadjuvant chemotherapy treatment</time_frame>
    <description>To evaluate self-reported data in terms of Sense of Coherence</description>
  </primary_outcome>
  <primary_outcome>
    <measure>European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ-C30)</measure>
    <time_frame>Up to 3 months after completion of neoadjuvant chemotherapy treatment</time_frame>
    <description>To evaluate self-reported data in terms of health related quality of life</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Questionnaire Memorial Symptom Assessment Scale (MSAS)</measure>
    <time_frame>Up to 3 months after completion of neoadjuvant chemotherapy treatment</time_frame>
    <description>To evaluate self-reported data in terms of symptom prevalence, characteristics and distress</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Health care costs</measure>
    <time_frame>Up to 3 months after completion of neoadjuvant chemotherapy treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of an application for a smartphone or tablet for daily reporting symptoms and access to self-care advice and health care professionals in real time in combination with standard care according to the clinic´s routines</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard care according to the clinic's routines.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Smartphone or tablet</intervention_name>
    <arm_group_label>Intervention group</arm_group_label>
    <other_name>Intervention</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The diagnosis of breast cancer

          -  Patients who will receive neoadjuvant chemotherapy

          -  Literacy in the Swedish language

        Exclusion Criteria:

          -  Patients who need an interpreter at the doctor's visit

          -  Patients who have a known severe cognitive impairment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ann Langius-Eklöf, RN, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska Institutet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <zip>17176</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 12, 2015</study_first_submitted>
  <study_first_submitted_qc>June 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2015</study_first_posted>
  <last_update_submitted>April 30, 2018</last_update_submitted>
  <last_update_submitted_qc>April 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Ann Langius-Eklöf</investigator_full_name>
    <investigator_title>RN, PhD, Professor</investigator_title>
  </responsible_party>
  <keyword>Breast Cancer</keyword>
  <keyword>Cytostatic Agents</keyword>
  <keyword>Nursing</keyword>
  <keyword>Health Literacy</keyword>
  <keyword>Quality of Life</keyword>
  <keyword>Oncology Nursing</keyword>
  <keyword>Self Care</keyword>
  <keyword>Symptom Management</keyword>
  <keyword>Participatory Care</keyword>
  <keyword>Person-centered Care</keyword>
  <keyword>Information and Communication Technology</keyword>
  <keyword>Patient-reported symptoms</keyword>
  <keyword>Mobile device</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

